![Sample our Behavioral Sciences journals, sign in here to start your access, latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110801/TOC-Subject-Sample-2021-Behavioral-Sciences.jpg"})
Abstract
Validity scales were recently developed to improve assessment of symptom validity beyond original MMPI-2 validity scales. In an initial study, the Response Bias Scale (RBS; CitationGervais, 2005) was developed based upon non-head-injury claimant performances on a cognitive effort measure, the Word Memory Test (WMT). The present study examined relationships of the RBS with numerous MMPI-2 validity scales in a sample of 211 participants with secondary gain (SG) or no secondary gain (NSG). Of the validity scales observed, RBS yielded the largest effect size difference between groups (d = .65), followed closely by FBS (d = .60) and the L-scale (d = .51). Overall, RBS correlated most significantly (r = .74, p < .001) with FBS, but also showed significant correlations with most other validity scales for both groups. RBS further demonstrated significant correlations (p < .001) with all clinical scales except for Mf. Findings suggest that RBS and FBS may represent a similar construct of symptom validity, and may outperform other MMPI-2 validity scales in discriminating SG and NSG groups. Findings provide preliminary support for use of RBS within the forensic context.
Notes
*Psychologists interested in obtaining the 39 MMPI-2 items that comprise RBS should contact Roger Gervais at [email protected].
Portions of this manuscript were presented at the final meeting of the American Academy of Clinical Neuropsychology in Minneapolis, MN, June 2005.
Sweet, J., Ecklund-Johnson, E., & Malina, A. (in press). Application of the new MMPI-2 Malingered Depression Scale to individuals undergoing neuropsychological evaluation: Relative lack of relationship to secondary gain and failure on validity indices. The Clinical Neuropsychologist.
